HomeInsightsStock Comparison

Akums Drugs Pharmaceuticals Ltd vs Alembic Pharmaceuticals Ltd Stock Comparison

Akums Drugs Pharmaceuticals Ltd vs Alembic Pharmaceuticals Ltd Stock Comparison

Last Updated on: Apr 27, 2025

Key Highlights

  • The Latest Trading Price of Akums Drugs & Pharmaceuticals Ltd is ₹ 530.6 as of 25 Apr 15:30.
  • The P/E Ratio of Akums Drugs & Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Alembic Pharmaceuticals Ltd changed from 12.1 on March 2020 to 31.4 on March 2024 . This represents a CAGR of 21.01% over 5 years.
  • The Market Cap of Akums Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Alembic Pharmaceuticals Ltd changed from ₹ 10059 crore on March 2020 to ₹ 19309 crore on March 2024 . This represents a CAGR of 13.93% over 5 years.
  • The revenue of Akums Drugs & Pharmaceuticals Ltd for the Dec '24 is ₹ 1029 crore as compare to the Sep '24 revenue of ₹ 1050 crore. This represent the decline of -1.95% The revenue of Alembic Pharmaceuticals Ltd for the Dec '24 is ₹ 1702 crore as compare to the Sep '24 revenue of ₹ 1678 crore. This represent the growth of 1.44%.
  • The ebitda of Akums Drugs & Pharmaceuticals Ltd for the Dec '24 is ₹ 140.71 crore as compare to the Sep '24 ebitda of ₹ 138.35 crore. This represent the growth of 1.71% The ebitda of Alembic Pharmaceuticals Ltd for the Dec '24 is ₹ 270.08 crore as compare to the Sep '24 ebitda of ₹ 269.74 crore. This represent the growth of 0.13%.
  • The net profit of Akums Drugs & Pharmaceuticals Ltd changed from ₹ -187 crore to ₹ 66.31 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Alembic Pharmaceuticals Ltd changed from ₹ 120.6 crore to ₹ 137.7 crore over 7 quarters. This represents a CAGR of 7.87% .
  • The Dividend Payout of Akums Drugs & Pharmaceuticals Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Alembic Pharmaceuticals Ltd changed from 19.45 % on March 2020 to 32.44 % on March 2024 . This represents a CAGR of 10.77% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Akums Drugs & Pharmaceuticals Ltd

  • Akums Drugs and Pharmaceuticals Limited was incorporated vide Certificate of Incorporation dated April 19, 2004 and received a Certificate for Commencement of Business dated May 13, 2004 issued by the RoC. Alkums Drugs & Pharmas are a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.
  • They are into sale of branded pharmaceutical formulations and manufacturing of Active Pharmaceutical Ingredients.
  • Some of the other services include formulation research and development, preparation and filing of regulatory dossiers into the Indian and global markets, and other testing services.
  • Some of manufacturing units have been accredited by various global regulatory agencies such as the European Good Manufacturing Practice, the World Health Organization Good Manufacturing Practice and the United States National Sanitation Foundation.

About Alembic Pharmaceuticals Ltd

  • Alembic Pharmaceuticals manufactures and markets generic pharmaceutical products all over the world.
  • The company's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the US FDA. The company is one of the leaders in branded generics in India. Alembic Pharmaceuticals Ltd was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Ltd. The company is engaged in pharmaceuticals business.
  • As per the scheme of arrangement, the 'Pharmaceutical Undertaking' of the Alembic Ltd was demerged and transferred to the company with effect from appointed date, April 1, 2010. In April 15, 2011, the company ceased to be a subsidiary of Alembic Ltd consequent to the allotment of 13,35,15,914 equity shares of Rs 2 each to the shareholders of Alembic Ltd as per the scheme of arrangement.

Akums Drugs & Pharmaceuticals Ltd News Hub

News

Akums Drugs & Pharmaceuticals to table results

Akums Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

01 Feb 2025 17:13

News

Akums Drugs drops as IT dept conducts search at its offices & units

'Income Tax Department conducted search under the Income Tax Act, 1961 at the offices and ...

Read more

22 Jan 2025 12:07

News

Akums Drugs rallies on inking pact to supply pharmaceutical formulations in Europe

The agreement is in line with Akums growth objective of expanding in European and other re...

Read more

24 Dec 2024 13:01

News

Akums Drugs ties up with Jagdale Inds for marketing of ready-to-drink nutritional beverages

This collaboration exclusively focuses on aseptic manufacturing and subsequent filling in ...

Read more

26 Nov 2024 12:47

News

Akums Drugs hits life high on inking pact with Caregen

Under the agreement, Akums was granted exclusive rights to sell a selection of Caregen's p...

Read more

19 Nov 2024 12:59

News

Akums Drugs & Pharmaceuticals to conduct board meeting

Akums Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

06 Nov 2024 15:48

Alembic Pharmaceuticals Ltd News Hub

News

Alembic Pharmaceuticals commissions new facility at Pithampur, Madhya Pradesh

Alembic Pharmaceuticals has commissioned a new manufacturing facility located at Pithampur...

Read more

26 Apr 2025 14:24

News

Alembic Pharmaceuticals to conduct board meeting

Alembic Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 ...

Read more

19 Apr 2025 10:36

News

Alembic Pharmaceuticals receives USFDA approval for Carbamazepine Tablets

Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the U...

Read more

17 Apr 2025 12:08

News

Alembic Pharma receives final approval for Carbamazepine tablets

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...

Read more

17 Apr 2025 12:13

News

Alembic Pharmaceuticals receives USFDA approval for Pantoprazole sodium for injection

Alembic Pharmaceuticals has received Final Approval from the US Food & Drug Administration...

Read more

02 Apr 2025 11:16

News

Alembic Pharma receives USFDA final approval for Pantoprazole Sodium Injection

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...

Read more

01 Apr 2025 13:17

SWOT Analysis Of Alembic Pharmaceuticals Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Akums Drugs & Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Alembic Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Akums Drugs & Pharmaceuticals Ltd and Alembic Pharmaceuticals Ltd

Which company has a larger market capitalization, Akums Drugs & Pharmaceuticals Ltd or Alembic Pharmaceuticals Ltd?

Market cap of Akums Drugs & Pharmaceuticals Ltd is 8,351 Cr while Market cap of Alembic Pharmaceuticals Ltd is 17,208 Cr

What are the key factors driving the stock performance of Akums Drugs & Pharmaceuticals Ltd and Alembic Pharmaceuticals Ltd?

The stock performance of Akums Drugs & Pharmaceuticals Ltd and Alembic Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Akums Drugs & Pharmaceuticals Ltd and Alembic Pharmaceuticals Ltd?

As of April 27, 2025, the Akums Drugs & Pharmaceuticals Ltd stock price is INR ₹530.6. On the other hand, Alembic Pharmaceuticals Ltd stock price is INR ₹875.45.

How do dividend payouts of Akums Drugs & Pharmaceuticals Ltd and Alembic Pharmaceuticals Ltd compare?

To compare the dividend payouts of Akums Drugs & Pharmaceuticals Ltd and Alembic Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions